S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
66,000% upside on tiny biotech? (Ad)
MarketBeat Week in Review – 9/18 - 9/22
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
66,000% upside on tiny biotech? (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
66,000% upside on tiny biotech? (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
66,000% upside on tiny biotech? (Ad)
MarketBeat Week in Review – 9/18 - 9/22
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
66,000% upside on tiny biotech? (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
66,000% upside on tiny biotech? (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
66,000% upside on tiny biotech? (Ad)
MarketBeat Week in Review – 9/18 - 9/22
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
66,000% upside on tiny biotech? (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
66,000% upside on tiny biotech? (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
66,000% upside on tiny biotech? (Ad)
MarketBeat Week in Review – 9/18 - 9/22
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
66,000% upside on tiny biotech? (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
66,000% upside on tiny biotech? (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
NASDAQ:CSII

Cardiovascular Systems (CSII) Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$20.00
$20.00
50-Day Range
$19.87
$20.00
52-Week Range
$12.26
$20.57
Volume
4,300 shs
Average Volume
765,906 shs
Market Capitalization
$843.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$20.00

Cardiovascular Systems MarketRank™ Forecast

Analyst Rating
Reduce
1.50 Rating Score
Upside/​Downside
N/A
Short Interest
N/A
Dividend Strength
N/A
Sustainability
-1.05
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.68) to ($0.51) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.04 out of 5 stars

Medical Sector

948th out of 968 stocks

Surgical & Medical Instruments Industry

88th out of 90 stocks


CSII stock logo

About Cardiovascular Systems (NASDAQ:CSII) Stock

Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St. Paul, MN.


CSII Stock News Headlines

New gold-backed currency could kill the Dollar
Rumors are circulating of a new currency that will be backed by gold. A huge story, if true. And while it’s impossible to know how it will pan out, there’s one important move you should make right now, before this happens. It’s the best way to protect your wealth today. Because if you’re not careful, YOU could be the one who pays the price
Cardiovascular Technologist
Holding NVDA? Read This Now
NVDA is likely not the best buy for A.I. investors. 50-year Wall Street veteran Marc Chaikin reveals what to buy instead. Learn more here.
Abbott Completes Acquisition of Cardiovascular Systems, Inc.
CSII Cardiovascular Systems, Inc.
See More Headlines
Receive CSII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardiovascular Systems and its competitors with MarketBeat's FREE daily newsletter.

CSII Company Calendar

Last Earnings
2/08/2023
Today
9/23/2023
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:CSII
CUSIP
14161910
Employees
780
Year Founded
1989

Price Target and Rating

Average Stock Price Forecast
$20.00
High Stock Price Forecast
$25.00
Low Stock Price Forecast
$15.00
Forecasted Upside/Downside
0.0%
Consensus Rating
Reduce
Rating Score (0-4)
1.50
Research Coverage
2 Analysts

Profitability

Net Income
$-36,930,000.00
Pretax Margin
-15.73%

Debt

Sales & Book Value

Annual Sales
$239.84 million
Book Value
$6.12 per share

Miscellaneous

Free Float
40,594,000
Market Cap
$843.96 million
Optionable
Optionable
Beta
0.74

Social Links

(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Scott R. WardScott R. Ward
    Chairman, President & Chief Executive Officer
  • John M. Hastings
    Executive Vice President-Operations & Technology
  • Jeffrey S. PointsJeffrey S. Points
    Chief Financial Officer
  • Jeffery W. Chambers
    Chief Medical Officer
  • Andrew P. O'Brien
    Vice President-Information Technology













CSII Stock - Frequently Asked Questions

Should I buy or sell Cardiovascular Systems stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardiovascular Systems in the last year. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "reduce" CSII shares.
View CSII analyst ratings
or view top-rated stocks.

What is Cardiovascular Systems' stock price forecast for 2023?

2 brokers have issued twelve-month price targets for Cardiovascular Systems' stock. Their CSII share price forecasts range from $15.00 to $25.00. On average, they expect the company's share price to reach $20.00 in the next year.
View analysts price targets for CSII
or view top-rated stocks among Wall Street analysts.

How were Cardiovascular Systems' earnings last quarter?

Cardiovascular Systems, Inc. (NASDAQ:CSII) posted its quarterly earnings results on Wednesday, February, 8th. The medical device company reported ($0.20) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.15) by $0.05. The medical device company earned $61.45 million during the quarter, compared to analysts' expectations of $63.06 million. Cardiovascular Systems had a negative trailing twelve-month return on equity of 15.39% and a negative net margin of 15.79%. The company's revenue for the quarter was up 3.9% compared to the same quarter last year. During the same quarter last year, the business posted ($0.23) earnings per share.

What is Scott Ward's approval rating as Cardiovascular Systems' CEO?

35 employees have rated Cardiovascular Systems Chief Executive Officer Scott Ward on Glassdoor.com. Scott Ward has an approval rating of 81% among the company's employees. 83.0% of employees surveyed would recommend working at Cardiovascular Systems to a friend.

What other stocks do shareholders of Cardiovascular Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardiovascular Systems investors own include Gilead Sciences (GILD), AbbVie (ABBV), Advanced Micro Devices (AMD), Medtronic (MDT), Pfizer (PFE), ACADIA Pharmaceuticals (ACAD), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK) and Procter & Gamble (PG).

What is Cardiovascular Systems' stock symbol?

Cardiovascular Systems trades on the NASDAQ under the ticker symbol "CSII."

Who are Cardiovascular Systems' major shareholders?

Cardiovascular Systems' stock is owned by many different retail and institutional investors. Top institutional shareholders include Walleye Trading LLC (0.00%), BROOKFIELD Corp ON (0.00%), Simplex Trading LLC (0.00%) and Picton Mahoney Asset Management (0.00%). Insiders that own company stock include Erik Paulsen, Jeffrey S Points, Martha Goldberg Aronson, Rhonda J Robb and Scott R Ward.
View institutional ownership trends
.

What is Cardiovascular Systems' stock price today?

One share of CSII stock can currently be purchased for approximately $20.00.

How much money does Cardiovascular Systems make?

Cardiovascular Systems (NASDAQ:CSII) has a market capitalization of $843.96 million and generates $239.84 million in revenue each year. The medical device company earns $-36,930,000.00 in net income (profit) each year or ($0.97) on an earnings per share basis.

How many employees does Cardiovascular Systems have?

The company employs 780 workers across the globe.

How can I contact Cardiovascular Systems?

Cardiovascular Systems' mailing address is 1225 OLD HWY 8 NW, ST. PAUL MN, 55112. The official website for the company is www.csi360.com. The medical device company can be reached via phone at (651) 259-1600, via email at j.nielsen@csi360.com, or via fax at 612-677-3355.

This page (NASDAQ:CSII) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -